Treatment of Co-occurring Anxiety Disorders and Substance Use Disorders
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Anxiety disorders commonly co-occur with substance use disorders both in the general population and in treatment-seeking samples. This co-occurrence is associated with greater symptom severity, higher levels of disability, and poorer course of illness relative to either disorder alone. Little research has been conducted, however, on the treatment of these co-occurring disorders. This gap may not only leave anxiety untreated or undertreated but also increase the risk for relapse and poor substance use outcomes. The aim of this article is to review the current state of the literature on treating co-occurring anxiety and substance use disorders. In addition to presenting a brief overview of the epidemiology of this co-occurrence, the article discusses the challenges in assessing anxiety in the context of a substance use disorder, the evidence for various treatment approaches, and recent advances and future directions in this understudied area. Also highlighted is the need for future research to identify optimal behavioral and pharmacologic treatments for co-occurring anxiety and substance use disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067 · cited 1×
“For example, the ResearchDomain Criteria (RDoC) initiative of the National Institute of Mental Health is examining core processes that may play a role in the development and maintenance of disorders across current diagnostic categories.(122)”
Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908 · cited 1×
“The prevalence of SUDs is approximately 9% for the past year(1,14) and over 10% and 30% lifetime for drug and alcohol use disorders, respectively.(4,15)”
BackgroundGrant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., & Kaplan, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.807 · Cited by 2,889
Neural Mechanisms of Extinction Learning and Retrieval
Quirk, G. J., & Mueller, D. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301555 · Cited by 1,645
Brown, T. A., Campbell, L. A., Lehman, C. L., Grisham, J. R., & Mancill, R. B. (2001) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.110.4.585 · Cited by 1,562
Hoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420
Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048
Pietrzak, R. H., Goldstein, R. B., Southwick, S. M., & Grant, B. F. (2011) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2010.11.010 · Cited by 963 · cited 1×
“Estimates from NESARC also suggest that over 46% of those with drug or alcohol use disorders have met full diagnostic criteria for PTSD during their lifetimes.(16) The rates of co-occurrence vary somewhat based on the drug of abuse, with higher rates of co-occurring ADs among those with drug use disorders, and higher…”
BackgroundBruce, S. E., Yonkers, K. A., Otto, M. W., Eisen, J. L., Weisberg, R. B., Pagano, M., Shea, M. T., & Keller, M. B. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1179 · Cited by 963 · cited 1×
“The co-occurrence of anxiety disorders (ADs) and substance use disorders (SUDs) is associated with greater symptom severity, greater functional impairment, and poorer course of illness than for either disorder alone.(6,9,10) Despite the substantial public health impact of this co-occurrence, little is known about the…”
BackgroundBarlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
Research works printed but not linked: 85
- Kessler, 2005, Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication., Arch Gen Psychiatry, 62, 593, 10.1001/archpsyc.62.6.593 · DOI · Paper page
- Kessler, 2007, Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organizations World Mental Health Survey Initiative., World Psychiatry, 6, 168
- Burns, 2005, The impact of comorbid anxiety and depression on alcohol treatment outcomes., Addiction, 100, 787, 10.1111/j.1360-0443.2005.001069.x · DOI · Paper page
- Magidson, 2012, Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample., J Psychiatr Res, 46, 659, 10.1016/j.jpsychires.2012.02.011 · DOI
- Najavits, 1998, Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study., Am J Psychiatry, 155, 214, 10.1176/ajp.155.2.214 · DOI · Paper page
- Schneider, 2001, Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first multicentre study in Germany., Alcohol Alcohol, 36, 219, 10.1093/alcalc/36.3.219 · DOI · Paper page
- Boschloo, 2012, Alcohol use disorders and the course of depressive and anxiety disorders., Br J Psychiatry, 200, 476, 10.1192/bjp.bp.111.097550 · DOI · Paper page
- Kessler, 2005, Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication., Arch Gen Psychiatry, 62, 617, 10.1001/archpsyc.62.6.617 · DOI · Paper page
- Kushner, 2000, The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings., Clin Psychol Rev, 20, 149, 10.1016/S0272-7358(99)00027-6 · DOI · Paper page
- Liappas, 2002, Impact of alcohol detoxification on anxiety and depressive symptoms., Drug Alcohol Depend, 68, 215, 10.1016/S0376-8716(02)00195-3 · DOI
- Cohn, 2003, Sequential studies of sleep disturbance and quality of life in abstaining alcoholics., Addict Biol, 8, 455, 10.1080/13556210310001646439 · DOI · Paper page
- Herrero, 2008, Psychiatric comorbidity in young cocaine users: induced versus independent disorders., Addiction, 103, 284, 10.1111/j.1360-0443.2007.02076.x · DOI · Paper page
- Torrens, 2011, Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders., Drug Alcohol Depend, 113, 147, 10.1016/j.drugalcdep.2010.07.013 · DOI · Paper page
- Buckner, 2008, Implications of comorbid alcohol dependence among individuals with social anxiety disorder., Depress Anxiety, 25, 1028, 10.1002/da.20442 · DOI · Paper page
- Schneier, 2010, Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions., Psychol Med, 40, 977, 10.1017/S0033291709991231 · DOI · Paper page
- Smith, 2010, Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment., Addict Behav, 35, 42, 10.1016/j.addbeh.2009.07.002 · DOI · Paper page
- Cottler, 2001, 3rd. Gender differences in risk factors for trauma exposure and post-traumatic stress disorder among inner-city drug abusers in and out of treatment., Compr Psychiatry, 42, 111, 10.1053/comp.2001.21219 · DOI
- Blanco, 2013, Comorbidity of posttraumatic stress disorder with alcohol dependence among US adults: results from National Epidemiological Survey on Alcohol and Related Conditions., Drug Alcohol Depend, 132, 630, 10.1016/j.drugalcdep.2013.04.016 · DOI · Paper page
- Swendsen, 2010, Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey., Addiction, 105, 1117, 10.1111/j.1360-0443.2010.02902.x · DOI · Paper page
- Breslau, 2003, Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma., Arch Gen Psychiatry, 60, 289, 10.1001/archpsyc.60.3.289 · DOI · Paper page
- de Graaf, 2013, First-incidence of DSM-IV mood, anxiety and substance use disorders and its determinants: results from the Netherlands Mental Health Survey and Incidence Study-2., J Affect Disord, 149, 100, 10.1016/j.jad.2013.01.009 · DOI
- Grant, 2009, Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions., Mol Psychiatry, 14, 1051, 10.1038/mp.2008.41 · DOI · Paper page
- Wolitzky-Taylor, 2012, Longitudinal investigation of the impact of anxiety and mood disorders in adolescence on subsequent substance use disorder onset and vice versa., Addict Behav, 37, 982, 10.1016/j.addbeh.2012.03.026 · DOI · Paper page
- Goodwin, 2004, Association between anxiety disorders and substance use disorders among young persons: results of a 21-year longitudinal study., J Psychiatr Res, 38, 295, 10.1016/j.jpsychires.2003.09.002 · DOI
- Driessen, 2001, The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders., Alcohol Alcohol, 36, 249, 10.1093/alcalc/36.3.249 · DOI · Paper page
- Tomasson, 1996, Psychopathology and alcohol consumption among treatment-seeking alcoholics: a prospective study., Addiction, 91, 1019, 10.1046/j.1360-0443.1996.91710198.x · DOI · Paper page
- Tomasson, 1997, The 2-year course following detoxification treatment of substance abuse: the possible influence of psychiatric comorbidity., Eur Arch Psychiatry Clin Neurosci, 247, 320, 10.1007/BF02922262 · DOI
- Marquenie, 2006, Comorbid phobic disorders do not influence outcome of alcohol dependence treatment. Results of a naturalistic follow-up study., Alcohol Alcohol, 41, 168, 10.1093/alcalc/agh252 · DOI · Paper page
- Trafton, 2006, Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder., J Stud Alcohol, 67, 228, 10.15288/jsa.2006.67.228 · DOI · Paper page
- Mills, 2007, The impact of post-traumatic stress disorder on treatment outcomes for heroin dependence., Addiction, 102, 447, 10.1111/j.1360-0443.2006.01711.x · DOI · Paper page
- Gil-Rivas, 2009, Substance use after residential treatment among individuals with co-occurring disorders: the role of anxietydepressive symptoms and trauma exposure., Psychol Addict Behav, 23, 303, 10.1037/a0015355 · DOI
- Hoertel, 2014, Do clinical trials of treatment of alcohol dependence adequately enroll participants with co-occurring independent mood and anxiety disorders An analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)., J Clin Psychiatry, 75, 231, 10.4088/JCP.13m08424 · DOI
- Dreifuss, 2013, Patient characteristics associated with buprenorphinenaloxone treatment outcome for prescription opioid dependence: results from a multisite study., Drug Alcohol Depend, 131, 112, 10.1016/j.drugalcdep.2012.12.010 · DOI
- Petrakis, 2006, Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder., Biol Psychiatry, 60, 777, 10.1016/j.biopsych.2006.03.074 · DOI
- OLeary, 2000, The relationship between anxiety levels and outcome of cocaine abuse treatment., Am J Drug Alcohol Abuse, 26, 179, 10.1081/ADA-100100599 · DOI
- Dundon, 2004, Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy., Alcohol Clin Exp Res, 28, 1065, 10.1097/01.ALC.0000130974.50563.04 · DOI · Paper page
- Kranzler, 2011, A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset and 5-hydroxytryptamine transporter-linked promoter region genotype., J Clin Psychopharmacol, 31, 22, 10.1097/JCP.0b013e31820465fa · DOI · Paper page
- Randall, 2001, Paroxetine for social anxiety and alcohol use in dual-diagnosed patients., Depress Anxiety, 14, 255, 10.1002/da.1077 · DOI · Paper page
- Thomas, 2008, A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking Alcohol Clin Exp R, es, 32, 77
- Brady, 2005, Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder., Alcohol Clin Exp Res, 29, 395, 10.1097/01.ALC.0000156129.98265.57 · DOI · Paper page
- Tollefson, 1992, Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone)., J Clin Psychopharmacol, 12, 19, 10.1097/00004714-199202000-00004 · DOI · Paper page
- Malcolm, 1992, A placebo-controlled trial of buspirone in anxious inpatient alcoholics., Alcohol Clin Exp Res, 16, 1007, 10.1111/j.1530-0277.1992.tb00691.x · DOI · Paper page
- McRae, 2004, A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals., Am J Addict, 13, 53, 10.1080/10550490490265325 · DOI
- Quitkin, 1972, Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse., Arch Gen Psychiatry, 27, 159, 10.1001/archpsyc.1972.01750260013002 · DOI · Paper page
- Nunes, 1995, Imipramine treatment of cocaine abuse: possible boundaries of efficacy., Drug Alcohol Depend, 39, 185, 10.1016/0376-8716(95)01161-6 · DOI · Paper page
- Nunes, 1998, Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial., Arch Gen Psychiatry, 55, 153, 10.1001/archpsyc.55.2.153 · DOI · Paper page
- Brady, 2005, Pharmacotherapy of comorbid mood, anxiety, and substance use disorders., Subst Use Misuse, 40, 2021, 10.1080/10826080500294924 · DOI · Paper page
- Ciraulo, 1996, Liability to alprazolam abuse in daughters of alcoholics., Am J Psychiatry, 153, 956, 10.1176/ajp.153.7.956 · doi:10.1176/ajp.153.7.956
- Busto, 1996, Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence., J Clin Psychopharmacol, 16, 51, 10.1097/00004714-199602000-00009 · DOI · Paper page
- Ross, 1993, Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics., Addiction, 88, 209, 10.1111/j.1360-0443.1993.tb00804.x · DOI · Paper page
- Adinoff, 1992, Long-term therapy with benzodiazepines despite alcohol dependence disorder., Am J Addict, 1, 288
- Mueller, 1996, Benzodiazepine use in anxiety disordered patients with and without a history of alcoholism., J Clin Psychiatry, 57, 83
- Mueller, 2005, Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders., Alcohol Clin Exp Res, 29, 1411, 10.1097/01.alc.0000175016.01790.f1 · DOI · Paper page
- Martinsen, 1998, Cognitive-behavioral group therapy for panic disorder in the general clinical setting: a naturalistic study with 1-year follow-up., J Clin Psychiatry, 59, 437, 10.4088/JCP.v59n0808 · DOI · Paper page
- Kaysen, 2014, Cognitive processing therapy for veterans with comorbid PTSD and alcohol use disorders., Addict Behav, 39, 420, 10.1016/j.addbeh.2013.08.016 · DOI · Paper page
- Ciraulo, 2013, The effects of venlafaxine and cognitive behavioral therapy alone and combined in the treatment of co-morbid alcohol use-anxiety disorders., Behav Res Ther, 51, 729, 10.1016/j.brat.2013.08.003 · DOI · Paper page
- Bowen, 2000, A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder., Addict Behav, 25, 593, 10.1016/S0306-4603(99)00017-9 · DOI
- Schade, 2005, The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial., Alcohol Clin Exp Res, 29, 794, 10.1097/01.ALC.0000163511.24583.33 · DOI · Paper page
- Schade, 2007, Anxiety disorders: treatable regardless of the severity of comorbid alcohol dependence., Eur Addict Res, 13, 109, 10.1159/000097941 · DOI · Paper page
- Petrakis, 2012, Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence., Neuropsychopharmacology, 37, 996, 10.1038/npp.2011.283 · DOI
- Krystal, 2008, Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, Naltrexone in the treatment of alcoholism., Alcohol Clin Exp Res, 32, 85, 10.1111/j.1530-0277.2007.00555.x · DOI
- Ouimette, 2003, PTSD treatment and 5-year remission among patients with substance use and posttraumatic stress disorders., J Consult Clin Psychol, 71, 410, 10.1037/0022-006X.71.2.410 · DOI · Paper page
- Kushner, 2009, Cognitive-behavioral therapy for panic disorder in patients being treated for alcohol dependence: moderating effects of alcohol outcome expectancies., Addict Behav, 34, 554, 10.1016/j.addbeh.2009.03.011 · DOI
- Kushner, 2006, Cognitive behavioral treatment of comorbid anxiety disorder in alcoholism treatment patients: presentation of a prototype program and future directions., J Ment Health, 15, 697, 10.1080/09638230600998946 · DOI
- Kushner, 2013, Hybrid cognitive behavioral therapy versus relaxation training for co-occurring anxiety and alcohol disorder: a randomized clinical trial., J Consult Clin Psychol, 81, 429, 10.1037/a0031301 · DOI · Paper page
- Desai, 2008, Impact of the seeking safety program on clinical outcomes among homeless female veterans with psychiatric disorders., Psychiatr Serv, 59, 996, 10.1176/ps.2008.59.9.996 · DOI
- Boden, 2012, Seeking safety treatment for male veterans with a substance use disorder and post-traumatic stress disorder symptomatology., Addiction, 107, 578, 10.1111/j.1360-0443.2011.03658.x · DOI · Paper page
- Hien, 2000, Posttraumatic stress disorder and short-term outcome in early methadone treatment., J Subst Abuse Treat, 19, 31, 10.1016/S0740-5472(99)00088-4 · DOI
- Hien, 2004, Promising treatments for women with comorbid PTSD and substance use disorders., Am J Psychiatry, 161, 1426, 10.1176/appi.ajp.161.8.1426 · DOI · Paper page
- McGovern, 2009, A cognitive behavioral therapy for co-occurring substance use and posttraumatic stress disorders., Addict Behav, 34, 892, 10.1016/j.addbeh.2009.03.009 · DOI · Paper page
- McGovern, 2011, A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders., J Dual Diagn, 7, 207, 10.1080/15504263.2011.620425 · DOI · Paper page
- Brady, 2001, Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: preliminary findings., J Subst Abuse Treat, 21, 47, 10.1016/S0740-5472(01)00182-9 · DOI · Paper page
- Baillie, 2013, An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: the Combined Alcohol Social Phobia (CASP) trial protocol., BMC Psychiatry, 13, 199, 10.1186/1471-244X-13-199 · DOI
- Buckner, 2014, Integrated cognitive behavioral therapy for cannabis use and anxiety disorders: rationale and development., Addict Behav, 39, 495, 10.1016/j.addbeh.2013.10.023 · DOI · Paper page
- Ouimette, 2010, Modeling associations between posttraumatic stress symptoms and substance use., Addict Behav, 35, 64, 10.1016/j.addbeh.2009.08.009 · DOI · Paper page
- Fox, 2013, Stress system changes associated with marijuana dependence may increase craving for alcohol and cocaine., Hum Psychopharmacol, 28, 40, 10.1002/hup.2280 · DOI · Paper page
- Rigg, 2010, Motivations for non-medical prescription drug use: a mixed methods analysis., J Subst Abuse Treat, 39, 236, 10.1016/j.jsat.2010.06.004 · DOI · Paper page
- Bertotto, 2006, Influence of ethanol withdrawal on fear memory: effect of D-cycloserine., Neuroscience, 142, 979, 10.1016/j.neuroscience.2006.07.013 · DOI
- Lattal, 2007, Effects of ethanol on encoding, consolidation, and expression of extinction following contextual fear conditioning., Behav Neurosci, 121, 1280, 10.1037/0735-7044.121.6.1280 · DOI · Paper page
- Tian, 2008, Prior chronic nicotine impairs cued fear extinction but enhances contextual fear conditioning in rats., Neuroscience, 153, 935, 10.1016/j.neuroscience.2008.03.005 · DOI
- Gu, 2008, Chronic morphine selectively impairs cued fear extinction in rats: implications for anxiety disorders associated with opiate use., Neuropsychopharmacology, 33, 666, 10.1038/sj.npp.1301441 · DOI
- Burke, 2006, Prior cocaine exposure disrupts extinction of fear conditioning., Learn Mem, 13, 416, 10.1101/lm.216206 · DOI · Paper page
- Back, 2014, Substance use disorders and PTSD: an exploratory study of treatment preferences among military veterans., Addict Behav, 39, 369, 10.1016/j.addbeh.2013.09.017 · DOI · Paper page
- 2008, Patients preferences within randomised trials: systematic review and patient level meta-analysis., BMJ, 337, a1864, 10.1136/bmj.a1864 · DOI · Paper page
- Burns, 2010, Do PTSD symptoms and course predict continued substance use for homeless individuals in contingency management for cocaine dependence Behav Res T, her, 48, 588
Cited by
Cook, J. A., Burke-Miller, J. K., Steigman, P. J., Schwartz, R. M., Hessol, N. A., Milam, J., Merenstein, D. J., Anastos, K., Golub, E. T., & Cohen, M. H. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2051-3 · Cited by 102
“Research shows that treating only one of these disorders does not improve the others, and that when only one is treated, significant distress and disability typically remain [52, 69].”
BackgroundBahji, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040999 · Cited by 83
McCabe, S. E., Schulenberg, J. E., Schepis, T. S., McCabe, V. V., & Veliz, P. T. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.5324 · Cited by 79
El Dib, R., Periyasamy, A. G., de Barros, J. L., França, C. G., Senefonte, F. L., Vesentini, G., Alves, M. G. O., Rodrigues, J. V. D. S., Gomaa, H., Gomes Júnior, J. R., et al. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.07.027 · Cited by 75
Luikinga, S. J., Kim, J. H., & Perry, C. J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.010 · Cited by 59
“Given that anxiety is highly co-morbid with SUD (McHugh, 2015), this augmented negative affect following adolescent exposure may partially explain any vulnerability toward emerging SUD.”
Background
Metadata
- Authors
- McHugh, R. K.
- Venue
- Harvard Review of Psychiatry
- Published
- 2015-03
- Volume
- 23
- Issue
- 2
- Pages
- 99-111
- ISSN
- 1067-3229 (ISSN-L)
- OpenAlex
- W2332108564
- Cited by
- 71
- References
- 33
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Co-occurring Anxiety Disorders and Substance Use Disorders. https://app.cochat.ai/papers/10.1097/hrp.0000000000000058
- The paper
- McHugh, R. K. (2015). Treatment of Co-occurring Anxiety Disorders and Substance Use Disorders. Harvard Review of Psychiatry. https://doi.org/10.1097/hrp.0000000000000058
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.